Suppr超能文献

WHIM 综合征中的 CXCR4 突变会损害 T 细胞免疫突触的稳定性。

The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse.

机构信息

Humanitas Clinical and Research Center, Rozzano, Milan, Italy.

出版信息

Blood. 2013 Aug 1;122(5):666-73. doi: 10.1182/blood-2012-10-461830. Epub 2013 Jun 21.

Abstract

WHIM (warts, hypogammaglobulinemia, infections, myelokathexis) syndrome is a rare disease characterized by diverse symptoms indicative of aberrantly functioning immunity. It is caused by mutations in the chemokine receptor CXCR4, which impair its intracellular trafficking, leading to increased responsiveness to chemokine ligand and retention of neutrophils in bone marrow. Yet WHIM symptoms related to adaptive immunity, such as delayed IgG switching and impaired memory B-cell function, remain largely unexplained. We hypothesized that the WHIM-associated mutations in CXCR4 may affect the formation of immunologic synapses between T cells and antigen-presenting cells (APCs). We show that, in the presence of competing external chemokine signals, the stability of T-APC conjugates from patients with WHIM-mutant CXCR4 is disrupted as a result of impaired recruitment of the mutant receptor to the immunologic synapse. Using retrogenic mice that develop WHIM-mutant T cells, we show that WHIM-mutant CXCR4 inhibits the formation of long-lasting T-APC interactions in ex vivo lymph node slice time-lapse microscopy. These findings demonstrate that chemokine receptors can affect T-APC synapse stability and allow us to propose a novel mechanism that contributes to the adaptive immune response defects in WHIM patients.

摘要

WHIM(疣、低丙种球蛋白血症、感染、骨髓细胞外噬)综合征是一种罕见疾病,其特征为多种表明免疫功能异常的症状。它是由趋化因子受体 CXCR4 的突变引起的,该突变会损害其细胞内运输,导致对趋化因子配体的反应过度和中性粒细胞在骨髓中的滞留。然而,WHIM 与适应性免疫相关的症状,如 IgG 转换延迟和记忆 B 细胞功能受损,在很大程度上仍未得到解释。我们假设 CXCR4 中的 WHIM 相关突变可能会影响 T 细胞和抗原呈递细胞(APC)之间免疫突触的形成。我们表明,在存在竞争的外部趋化因子信号的情况下,WHIM 突变型 CXCR4 患者的 TAPC 共轭物的稳定性由于突变受体向免疫突触募集的受损而被破坏。使用产生 WHIM 突变型 T 细胞的转基因小鼠,我们表明 WHIM 突变型 CXCR4 抑制了在体外淋巴结切片延时显微镜检查中长时间 TAPC 相互作用的形成。这些发现表明,趋化因子受体可以影响 TAPC 突触稳定性,并使我们能够提出一种新的机制,该机制有助于 WHIM 患者适应性免疫反应缺陷。

相似文献

5
Adaptive Immunodeficiency in WHIM Syndrome.WHIM 综合征中的适应性免疫缺陷。
Int J Mol Sci. 2018 Dec 20;20(1):3. doi: 10.3390/ijms20010003.
7
CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome.作为WHIM综合征潜在治疗药物的CXCR4特异性纳米抗体
J Pharmacol Exp Ther. 2017 Oct;363(1):35-44. doi: 10.1124/jpet.117.242735. Epub 2017 Aug 2.

引用本文的文献

5
The complex nature of CXCR4 mutations in WHIM syndrome.WHIM 综合征中 CXCR4 突变的复杂性。
Front Immunol. 2024 Jul 5;15:1406532. doi: 10.3389/fimmu.2024.1406532. eCollection 2024.

本文引用的文献

1
8
AMD3100 is a CXCR7 ligand with allosteric agonist properties.AMD3100是一种具有变构激动剂特性的CXCR7配体。
Mol Pharmacol. 2009 May;75(5):1240-7. doi: 10.1124/mol.108.053389. Epub 2009 Mar 2.
9
WHIM syndrome: congenital immune deficiency disease.维姆综合征:先天性免疫缺陷病。
Curr Opin Hematol. 2009 Jan;16(1):20-6. doi: 10.1097/MOH.0b013e32831ac557.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验